Asston Pharmaceuticals Limited has officially confirmed the record date for its Extraordinary General Meeting (EGM) scheduled for April 28, 2026, at 12:30 P.M. The company has set April 17, 2026, as the cut-off date for determining shareholder eligibility to participate in the voting process, in compliance with regulatory requirements.

Meeting Details and Voting Arrangements

The EGM will be conducted through video conferencing in compliance with regulatory guidelines and will address several important corporate governance matters. Remote e-voting will be available through NSDL's platform from April 23, 2026, at 09:00 A.M. to April 27, 2026, at 05:00 P.M.

Regulatory Compliance Framework

The meeting follows provisions under Section 108 of the Companies Act, 2013, read with Rule 20 of the Companies (Management and Administration) Rules, 2014, and Regulation 44 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015. The company has arranged e-voting facility through National Securities Depository Limited (NSDL) for members to participate in the business transactions.

Agenda Items for Approval

The EGM will consider four key resolutions covering auditor appointment and director regularizations. The primary agenda involves appointing M/s Panchal SK & Associates, Chartered Accountants (Firm Registration No. 145989W), as statutory auditors to address the casual vacancy created by the resignation of M/s. Doshi Doshi & Co., Chartered Accountants.

Participation Guidelines

The meeting follows Ministry of Corporate Affairs guidelines allowing virtual meetings through video conferencing. The facility will accommodate at least 1,000 members on a first-come, first-served basis, excluding large shareholders, promoters, institutional investors, and key personnel who have unrestricted access. M/s Praggya & Associates, Company Secretaries, has been appointed as scrutinizer for the e-voting process to ensure fair and transparent voting procedures.

Asston Pharmaceuticals Limited successfully concluded its board meeting on March 30, 2026, implementing significant leadership changes and corporate governance measures. The meeting, conducted from 03:00 P.M. to 04:00 P.M. via video conferencing at the registered office, resulted in the approval of key appointments and scheduling of an Extraordinary General Meeting.

Board Meeting Outcomes

The board meeting concluded with the successful implementation of all proposed agenda items under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015:

Key Leadership Appointments

Mr. Sumit Pawar brings over 3 years of experience in finance and accounting management to his new role as Chief Financial Officer. As a Commerce graduate, he possesses understanding of diverse business processes and strategy development, with expertise expected to enhance the company's financial models and strategic planning capabilities. His association with the company is anticipated to provide operational and financial efficacy.

Mr. Yashvardhan Tupe, appointed as Additional Non-Executive Director, holds a Bachelor's degree in Mechanical Engineering and a Master of Science in Management and International Business. His strong academic background and relevant exposure, particularly aligned with operational and strategic aspects of the manufacturing industry, positions him to contribute effectively to the company's growth, governance framework, and long-term business strategy.

Independent Director Addition

Mr. Sandip Sharma's appointment as Additional Non-Executive Independent Director strengthens the board's independence. As a qualified Company Secretary with over two years of professional experience in corporate law, governance, and regulatory compliance, he has successfully cleared the Independent Director Examination conducted by the Indian Institute of Corporate Affairs and holds the Certificate of Independent Director. His expertise encompasses Companies Act, SEBI regulations, corporate governance frameworks, and secretarial standards.

Regulatory Compliance and EGM Planning

The company maintained strict adherence to regulatory requirements, with all appointments taking immediate effect from March 30, 2026. The board approved the Extraordinary General Meeting scheduled for April 28, 2026, at 12:30 PM through Video Conferencing or Other Audio Visual Means. Company Secretary and Compliance Officer Rishi Upadhaya signed the regulatory filing to BSE Limited, ensuring transparent communication and maintaining the company's commitment to regulatory compliance.

All appointed personnel confirmed no relationships with existing board directors, maintaining governance independence standards as required under SEBI regulations.